Shares Outstanding | 1,613,911 shares |
Insider Shares | 16,667,513 shares |
Total Insiders | 61 |
Insider Sentiment Score
The Insider Sentiment Score finds the companies being bought by corporate insiders.
It is the result of a sophisticated, multi-factor quantitative model that identifies companies with the highest levels of insider accumulation. The scoring model uses a combination of the net number of insiders buying the prior 90 days, the total shares bought as a percentage of float, and the total shares owned by insiders. The number ranges from 0 to 100, with higher numbers indicating a higher level of accumulation to its peers, and 50 being the average.
Update Frequency: Daily
See Insiders Top Picks, which provides a list of companies with highest insider accumulation.
Officer Sentiment Score
The Officer Sentiment Score finds companies being bought by Corporate Officers.
By definition Corporate Officers are Corporate Insiders, but unlike some of the other Insiders (10% Shareholders and Board Members), Officers work for the company on a daily basis, and they user their own money when trading. (10% Shareholders and Board Members are often fund managers managing other people’s money.) As such, insider trades made by Officers are much more significant and should be treated appropriately.
Like the Insider Sentiment Score, the Officer Sentiment Score is the result of a sophisticated, multi-factor quantitative model that identifies companies with the highest levels of officer accumulation.
Update Frequency: Daily
See Insiders Top Picks, which provides a list of companies with highest insider sentiment.
Key Insider Metrics
This card shows how the company ranks along various insider metrics. The percentile rank shows how this company compares to other companies in the US markets. Higher rankings are indicative of better situations.
For example, it is generally accepted that insider buying is a positive indicator, so companies with more insider buying would rank higher than companies with less insider buying (or even insider selling).
Insider Trading Chart
MedAvail Holdings, Inc. insider trades are shown in the following chart. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on material, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Roster and Profitability Metrics
This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings. Additionally, when possible we provide the historical trade performance for the insider. The historical trade performance is a weighted average of the performance of actual open-market purchase transactions made by the insider. For more information on how this is calculated, watch this YouTube webinar.
See our leaderboard of most profitable insider traders.
Insider | Avg Profit (%) | Shares Owned |
Split Adjusted |
---|---|---|---|
ABG Management Ltd.
10% Owner -
|
2,920,780 | 117,898 | |
WTT-MedAvail Ltd ABG
10% Owner -
|
5,894,897 | 117,898 | |
ABG-WTT Global Life Science Capital Partners GP Ltd
10% Owner -
|
2,920,780 | 117,898 | |
ABG-WTT Global Life Science Capital Partners GP, L.P.
10% Owner -
|
2,920,780 | 117,898 | |
Buzz Aldrin Director - [D] | 100,000 | 100,000 | |
Ally Bridge Group (NY) LLC
10% Owner -
|
1,487,058 | 117,898 | |
Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.
10% Owner -
|
2,920,780 | 117,898 | |
Ally Bridge MedAlpha Management GP, LLC
10% Owner -
|
2,920,780 | 58,416 | |
Ally Bridge MedAlpha Management L.P.
10% Owner -
|
2,920,780 | 58,416 | |
Ally Bridge MedAlpha Master Fund L.P.
10% Owner -
|
2,920,780 | 117,898 | |
Alyeska Investment Group, L.P.
10% Owner -
|
7,539,411 | 150,788 | |
Aronne Louis J. Director - [D] | 80,705 | 80,705 | |
Ashton Robert C. Jr. | 10,000 | ||
Helen Ciesielski | 0 | ||
Carl DeFreitas Interim CFO - [O] | 1,000 | 1,000 | |
Christopher C Dewey Director - [D] | 328,982 | 328,982 | |
Janine DiVenuto
10% Owner -
|
7,757,000 | 7,757,000 | |
Peter Diamandis Director - [D] | 5,444 | 5,444 | |
Mark Edward Doerr Chief Executive Officer, Director - [D] [O] | 188,701 | 3,774 | |
Joseph DosSantos Interim President and CFO - [O] | 5,000 | 5,000 |
Insider | Avg Profit (%) | Shares Owned |
Split Adjusted |
---|---|---|---|
Einhorn Andrew J. | 0 | ||
Faulkner Robert C. | 0 | ||
Ryan Ferguson | 249,319 | ||
Fleischer Glen R. - | 0 | 0 | |
Gerald Gradwell | 215,815 | ||
Jeremy Green
Director, 10% Owner -
[D]
|
7,058,821 | 381,956 | |
Robert J Hariri Director - [D] | 119,364 | 119,364 | |
Steven Hess | 131,000 | ||
Paul D Johnson | 86,372 | ||
Edwin Kilroy | 876,723 | ||
Michael R Kramer | 14,165 | ||
Jack Levine Director - [D] | 27,000 | 27,000 | |
Zhengguang Lyu Director - [D] | 122,228 | 122,228 | |
Peter Levy COO; Executive VP - [O] | 750,000 | 750,000 | |
Victor E Mandel Director - [D] | 120,377 | 120,377 | |
David J Matlin
10% Owner -
|
1,267,477 | 1,267,477 | |
Laurie Mcgraw | 86,372 | ||
Fraser Mackay | 113,175 | ||
Joseph Mannello Chief Executive Officer, Director - [D] [O] | 1,567,557 | 1,567,557 | |
Will Misloski | 0 |
Insider | Avg Profit (%) | Shares Owned |
Split Adjusted |
---|---|---|---|
John Nosta Director - [D] | 32,274 | 32,274 | |
Anand Parekh
10% Owner -
|
7,539,411 | 150,788 | |
Christopher Pechock Director - [D] | 385,257 | 385,257 | |
Andrew Joel Ponte Director - [D] | 97,499 | 97,499 | |
Neil Prezioso | 0 | ||
Ren Ren
Director, 10% Owner -
[D]
|
18,182 | 18,182 | |
Agriculture Science & Technology Co, Ltd RENS
10% Owner -
|
3,000,000 | 3,000,000 | |
RENS Technology Inc
10% Owner -
|
3,000,000 | 3,000,000 | |
Dave Rawlins | 298,950 | ||
RedCo II Master Fund, L.P.
Director, 10% Owner -
[D]
|
11,458,679 | 381,956 | |
Redmile Group, LLC
Director, 10% Owner -
[D]
|
19,097,796 | 381,956 | |
Ramona Seabaugh Chief Financial Officer - [O] | 1,222 | 1,222 | |
Sapna Srivastava Director - [D] | 200,000 | 200,000 | |
Stettin Glen D. | 14,165 | ||
Kenrick Bryce Toussaint Chief Executive Officer - [O] | 10,000 | 10,000 | |
John Craig Venter | 3,000 | ||
Fan Yu
10% Owner -
|
2,920,780 | 117,898 | |
Guiying Zhao | 0 | ||
Eric Zaltas Director - [D] | 16,529 | 16,529 | |
Bin Zhou | 0 | ||
Hamel Platerink Gerard van | 0 |
Report errors via our new Insider Auditing Tool
Track Records of Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made in MDVLQ / MedAvail Holdings, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical .
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Track Records of Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in MDVLQ / MedAvail Holdings, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical .
The following table shows the most recent open market sales that were not part of an automatic trading plan.
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Transaction History
Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.
File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-10-02 | 2023-09-28 | 4 | Seabaugh Ramona | MDVL | Common Stock | D | 5.6971 | -303 | -2 | 1,222 | ||||
2023-10-02 | 2023-09-01 | 4 | Seabaugh Ramona | MDVL | Common Stock | D | 680 | 1,525 | ||||||
2023-03-23 | 2023-03-21 | 4 | Seabaugh Ramona | MDVL | Common Stock | D | 0.3070 | -3,287 | -1 | 18,319 | ||||
2023-03-07 | 2023-03-03 | 4 | Seabaugh Ramona | MDVL | Common Stock | D | 0.3366 | -6,727 | -2 | 21,606 | ||||
2023-03-07 | 2023-03-06 | 4 | Doerr Mark Edward | MDVL | Common Stock | D | 0.3112 | -72,785 | -23 | 188,701 | ||||
2023-03-07 | 2023-03-03 | 4 | Doerr Mark Edward | MDVL | Common Stock | D | 0.3262 | -20,773 | -7 | 261,486 | ||||
2023-03-03 | 2023-03-01 | 4 | Seabaugh Ramona | MDVL | Common Stock | D | 20,000 | 28,333 | ||||||
2023-03-03 | 2023-03-01 | 4 | Seabaugh Ramona | MDVL | Common Stock | D | 8,333 | 8,333 | ||||||
2023-03-03 | 2023-03-01 | 4 | Doerr Mark Edward | MDVL | Common Stock | D | 282,259 | 282,259 | ||||||
2022-07-06 | 2022-07-01 | 4 | Redmile Group, LLC | MDVL | Common Stock | D | 1.0625 | 7,639,117 | 8,117 | 19,097,796 | ||||
2022-07-06 | 2022-07-01 | 4 | Redmile Group, LLC | MDVL | Common Stock | I | 1.0625 | 9,411,765 | 10,000 | 34,604,516 | ||||
2022-05-23 | 3 | PAREKH ANAND | MDVL | Common Stock | D | 7,539,411 | ||||||||
2022-05-23 | 3 | PAREKH ANAND | MDVL | Common Stock | D | 7,539,411 | ||||||||
2022-05-23 | 3 | PAREKH ANAND Footnotes | MDVL | Common Stock | I | 7,539,411 | ||||||||
2022-05-23 | 3 | PAREKH ANAND Footnotes | MDVL | Common Stock | I | 7,539,411 | ||||||||
2022-05-23 | 3 | PAREKH ANAND Footnotes | MDVL | Common Stock | I | 7,539,411 | ||||||||
2022-05-23 | 3 | PAREKH ANAND Footnotes | MDVL | Common Stock | I | 7,539,411 | ||||||||
2022-04-12 | 2022-04-08 | 4 | Hess Steven | MDVL | Stock Option (Right to Buy) | D | 1.96 | 131,000 | 131,000 | |||||
2022-04-12 | 2022-04-08 | 4 | Hess Steven | MDVL | Restricted Stock Units | D | 131,000 | 131,000 | ||||||
2022-04-06 | 3 | RedCo II Master Fund, L.P. | MDVL | Common Stock | D | 11,458,679 | ||||||||
2022-04-06 | 2022-04-04 | 4 | Redmile Group, LLC | MDVL | Warrants to Purchase Shares of Common Stock | I | 1.25 | 7,058,821 | 7,058,821 | |||||
2022-04-06 | 2022-04-04 | 4 | Redmile Group, LLC | MDVL | Common Stock | I | 1.0625 | 14,117,646 | 15,000 | 25,192,751 | ||||
2022-04-06 | 2022-04-04 | 4 | ABG WTT-MedAvail Ltd | MDVL | Warrant (Right to Buy) | I | 1.25 | 1.0625 | 1,487,058 | 1,580 | 1,487,058 | |||
2022-04-06 | 2022-04-04 | 4 | ABG WTT-MedAvail Ltd | MDVL | Warrant (Right to Buy) | I | 1.25 | 1.0625 | 5,571,764 | 5,920 | 5,571,764 | |||
2022-04-06 | 2022-04-04 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 1.0625 | 2,974,117 | 3,160 | 5,894,897 | ||||
2022-04-06 | 2022-04-04 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 1.0625 | 11,143,529 | 11,840 | 15,029,480 | ||||
2022-03-18 | 2022-03-16 | 4 | Seabaugh Ramona | MDVL | Stock Option (Right to Buy) | D | 0.83 | 60,000 | 60,000 | |||||
2022-03-18 | 2022-03-16 | 4 | Seabaugh Ramona | MDVL | Restricted Stock Units | D | 60,000 | 60,000 | ||||||
2022-03-18 | 2022-03-16 | 4 | Johnson Paul D | MDVL | Common Stock | D | 0.83 | 86,372 | 86,372 | |||||
2022-03-18 | 2022-03-16 | 4 | MCGRAW LAURIE | MDVL | Common Stock | D | 0.83 | 86,372 | 86,372 | |||||
2022-02-14 | 2022-02-09 | 4 | Seabaugh Ramona | MDVL | Restricted Stock Units | D | 25,000 | 25,000 | ||||||
2022-02-14 | 2022-02-09 | 4 | Seabaugh Ramona | MDVL | Stock Option (Right to Buy) | D | 1.38 | 25,000 | 25,000 | |||||
2022-01-12 | 2022-01-10 | 4 | Doerr Mark Edward | MDVL | Restricted Stock Units | D | 846,775 | 846,775 | ||||||
2022-01-12 | 2022-01-10 | 4 | Doerr Mark Edward | MDVL | Stock Option (Right to Buy) | D | 1.24 | 1,173,127 | 1,173,127 | |||||
2021-07-02 | 2021-06-30 | 4 | Kramer Michael R | MDVL | Stock Option (Right to Buy) | D | 12.25 | 18,438 | 18,438 | |||||
2021-07-02 | 2021-06-30 | 4 | Stettin Glen D. | MDVL | Stock Option (Right to Buy) | D | 12.25 | 18,438 | 18,438 | |||||
2021-07-02 | 2021-06-30 | 4 | Gradwell Gerald | MDVL | Stock Option (Right to Buy) | D | 12.25 | 18,438 | 18,438 | |||||
2021-03-25 | 2021-03-22 | 4 | Prezioso Neil | MDVL | Restricted Stock Units | D | 3,465 | 201,963 | ||||||
2021-03-25 | 2021-03-22 | 4 | Prezioso Neil | MDVL | Stock Option (Right to Buy) | D | 15.15 | 18,794 | 198,498 | |||||
2021-03-25 | 2021-03-22 | 4 | Misloski Will | MDVL | Restricted Stock Units | D | 2,145 | 202,405 | ||||||
2021-03-25 | 2021-03-22 | 4 | Misloski Will | MDVL | Stock Option (Right to Buy) | D | 15.15 | 11,634 | 200,260 | |||||
2021-03-25 | 2021-03-22 | 4 | Ferguson Ryan | MDVL | Restricted Stock Units | D | 2,821 | 267,444 | ||||||
2021-03-25 | 2021-03-22 | 4 | Ferguson Ryan | MDVL | Stock Option (Right to Buy) | D | 15.15 | 15,304 | 264,623 | |||||
2021-03-25 | 2021-03-22 | 4 | Kilroy Edwin | MDVL | Restricted Stock Units | D | 5,897 | 914,604 | ||||||
2021-03-25 | 2021-03-22 | 4 | Kilroy Edwin | MDVL | Stock Option (Right to Buy) | D | 15.15 | 31,984 | 908,707 | |||||
2021-01-08 | 2021-01-06 | 4 | Kramer Michael R | MDVL | Common Stock | D | 13.27 | 14,165 | 14,165 | |||||
2021-01-08 | 2021-01-06 | 4 | Stettin Glen D. | MDVL | Common Stock | D | 13.27 | 14,165 | 14,165 | |||||
2021-01-08 | 2021-01-06 | 4 | Gradwell Gerald | MDVL | Stock Option (Right to Buy) | D | 13.27 | 14,165 | 215,815 | |||||
2021-01-05 | 2020-12-31 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 14.9959 | 5,727 | 86 | 2,920,780 | ||||
2021-01-05 | 2020-12-31 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 14.9959 | 6,943 | 104 | 3,885,951 | ||||
2020-12-30 | 2020-12-29 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 14.0000 | 45 | 1 | 2,915,053 | ||||
2020-12-30 | 2020-12-29 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 14.0000 | 55 | 1 | 3,879,008 | ||||
2020-12-30 | 2020-12-28 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.9766 | 3,213 | 45 | 2,915,008 | ||||
2020-12-30 | 2020-12-28 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.9766 | 3,894 | 54 | 3,878,953 | ||||
2020-12-28 | 2020-12-24 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.9919 | 4,019 | 56 | 2,911,795 | ||||
2020-12-28 | 2020-12-24 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.9919 | 4,871 | 68 | 3,875,059 | ||||
2020-12-28 | 2020-12-23 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.9865 | 9,810 | 137 | 2,907,776 | ||||
2020-12-28 | 2020-12-23 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.9865 | 11,890 | 166 | 3,870,188 | ||||
2020-12-28 | 2020-12-22 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.7016 | 7,661 | 105 | 2,897,966 | ||||
2020-12-28 | 2020-12-22 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.7016 | 9,287 | 127 | 3,858,298 | ||||
2020-12-22 | 2020-12-21 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.3147 | 7,358 | 98 | 2,890,305 | ||||
2020-12-22 | 2020-12-21 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.3147 | 8,919 | 119 | 3,849,011 | ||||
2020-12-22 | 2020-12-18 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.5946 | 8,408 | 114 | 2,882,947 | ||||
2020-12-22 | 2020-12-18 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.5946 | 10,192 | 139 | 3,840,092 | ||||
2020-12-18 | 2020-12-17 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 14.0000 | 1,029 | 14 | 2,874,539 | ||||
2020-12-18 | 2020-12-17 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 14.0000 | 1,248 | 17 | 3,829,900 | ||||
2020-12-18 | 2020-12-17 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.1201 | 5,731 | 75 | 2,873,510 | ||||
2020-12-18 | 2020-12-17 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.1201 | 6,946 | 91 | 3,828,652 | ||||
2020-12-18 | 2020-12-16 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.0611 | 12,851 | 168 | 2,867,779 | ||||
2020-12-18 | 2020-12-16 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.0611 | 15,578 | 203 | 3,821,706 | ||||
2020-12-16 | 2020-12-15 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.0821 | 9,027 | 118 | 2,854,928 | ||||
2020-12-16 | 2020-12-15 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 13.0821 | 10,942 | 143 | 3,806,128 | ||||
2020-12-16 | 2020-12-15 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 12.4955 | 4,276 | 53 | 2,845,901 | ||||
2020-12-16 | 2020-12-15 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 12.4955 | 5,184 | 65 | 3,795,186 | ||||
2020-12-16 | 2020-12-14 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 12.2443 | 6,535 | 80 | 2,841,625 | ||||
2020-12-16 | 2020-12-14 | 4 | ABG WTT-MedAvail Ltd | MDVL | Common Stock | I | 12.2443 | 7,922 | 97 | 3,790,002 | ||||
2020-11-30 | 3 | Ally Bridge Group (NY) LLC See footnotes | MDVL | Common Stock | I | 3,782,080 | ||||||||
2020-11-30 | 3 | Ally Bridge Group (NY) LLC See footnotes | MDVL | Common Stock | I | 2,835,090 | ||||||||
2020-11-27 | 3 | Green Jeremy | MDVL | Common Stock | I | 11,724,726 | ||||||||
2020-11-18 | 2020-11-17 | 4 | Rawlins Dave | MDVL | Stock Option (Right to Buy) | D | 1.71 | 74,320 | 298,950 | |||||
2020-11-18 | 2020-11-17 | 4 | Rawlins Dave | MDVL | Stock Option (Right to Buy) | D | 1.71 | 224,630 | 224,630 | |||||
2020-11-18 | 2020-11-17 | 4 | Mackay Fraser | MDVL | Stock Option (Right to Buy) | D | 2.09 | 48,559 | 113,175 | |||||
2020-11-18 | 2020-11-17 | 4 | Mackay Fraser | MDVL | Stock Option (Right to Buy) | D | 2.09 | 16,876 | 64,616 | |||||
2020-11-18 | 2020-11-17 | 4 | Mackay Fraser | MDVL | Stock Option (Right to Buy) | D | 2.09 | 47,740 | 47,740 | |||||
2020-11-18 | 2020-11-17 | 4 | Kilroy Edwin | MDVL | Stock Option (Right to Buy) | D | 1.71 | 42,325 | 876,723 | |||||
2020-11-18 | 2020-11-17 | 4 | Kilroy Edwin | MDVL | Stock Option (Right to Buy) | D | 2.09 | 5,136 | 834,398 | |||||
2020-11-18 | 2020-11-17 | 4 | Kilroy Edwin | MDVL | Stock Option (Right to Buy) | D | 2.09 | 92,160 | 829,262 | |||||
2020-11-18 | 2020-11-17 | 4 | Kilroy Edwin | MDVL | Stock Option (Right to Buy) | D | 2.09 | 108,388 | 737,102 | |||||
2020-11-18 | 2020-11-17 | 4 | Kilroy Edwin | MDVL | Stock Option (Right to Buy) | D | 2.09 | 127,171 | 628,714 | |||||
2020-11-18 | 2020-11-17 | 4 | Kilroy Edwin | MDVL | Stock Option (Right to Buy) | D | 2.09 | 81,715 | 501,543 | |||||
2020-11-18 | 2020-11-17 | 4 | Kilroy Edwin | MDVL | Stock Option (Right to Buy) | D | 2.09 | 350,811 | 419,828 | |||||
2020-11-18 | 2020-11-17 | 4 | Kilroy Edwin | MDVL | Stock Option (Right to Buy) | D | 2.09 | 28,512 | 69,017 | |||||
2020-11-18 | 2020-11-17 | 4 | Kilroy Edwin | MDVL | Stock Option (Right to Buy) | D | 2.09 | 40,505 | 40,505 | |||||
2020-11-18 | 2020-11-17 | 4 | Gradwell Gerald Dowth International Limited | MDVL | Warrant (Right to Buy) | I | 1.57 | 201,650 | 201,650 | |||||
2020-11-18 | 2020-11-17 | 4 | Misloski Will | MDVL | Stock Option (Right to Buy) | D | 2.09 | 188,626 | 188,626 | |||||
2020-11-18 | 2020-11-17 | 4 | Prezioso Neil | MDVL | Stock Option (Right to Buy) | D | 1.71 | 179,704 | 179,704 | |||||
2020-11-18 | 2020-11-17 | 4 | Ferguson Ryan | MDVL | Stock Option (Right to Buy) | D | 1.71 | 249,319 | 249,319 | |||||
2020-10-02 | 2020-10-01 | 4 | Mannello Joseph | MYOS | Common Stock | D | 180,000 | 1,567,557 | ||||||
2020-04-06 | 2020-03-31 | 4 | Dewey Christopher C | MYOS | Common Stock | D | 6,611 | 328,982 | ||||||
2020-04-06 | 2020-03-31 | 4 | PECHOCK CHRISTOPHER | MYOS | Common Stock | D | 45,455 | 385,257 | ||||||
2020-04-06 | 2020-03-31 | 4 | Mannello Joseph | MYOS | Common Stock | D | 16,529 | 1,387,557 | ||||||
2020-04-06 | 2020-03-31 | 4 | MANDEL VICTOR E | MYOS | Common Stock | D | 41,322 | 120,377 | ||||||
2020-04-06 | 2020-03-31 | 4 | Hariri Robert J | MYOS | Common Stock | D | 3,306 | 119,364 | ||||||
2020-04-06 | 2020-03-31 | 4 | Aronne Louis J. | MYOS | Common Stock | D | 29,752 | 80,705 | ||||||
2020-04-06 | 2020-03-31 | 4 | Zaltas Eric | MYOS | Common Stock | D | 16,529 | 16,529 | ||||||
2020-04-06 | 2020-03-31 | 4 | Ponte Andrew Joel | MYOS | Common Stock | D | 3,306 | 97,499 | ||||||
2020-03-10 | 2020-03-06 | 4 | MATLIN DAVID J | MYOS | Common Stock | D | 1.2100 | 206,611 | 250 | 1,267,477 | ||||
2020-03-09 | 2020-03-05 | 4 | Ponte Andrew Joel | MYOS | Common Stock | D | 1.2100 | 82,645 | 100 | 94,193 | ||||
2020-03-09 | 2020-03-05 | 4 | Dewey Christopher C | MYOS | Common Stock | D | 1.2100 | 82,645 | 100 | 322,371 | ||||
2020-03-09 | 2020-03-05 | 4 | PECHOCK CHRISTOPHER | MYOS | Common Stock | D | 1.2100 | 82,645 | 100 | 339,802 | ||||
2020-03-09 | 2020-03-05 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.2100 | 681,818 | 825 | 1,371,028 | ||||
2020-02-12 | 3 | Ponte Andrew Joel | MYOS | Common Stock | D | 23,096 | ||||||||
2020-02-12 | 3 | Ponte Andrew Joel | MYOS | Common Stock | D | 23,096 | ||||||||
2020-02-12 | 3 | Ponte Andrew Joel | MYOS | Common Stock | D | 23,096 | ||||||||
2019-08-19 | 3 | Dewey Christopher C | MYOS | Common Stock | D | 479,452 | ||||||||
2019-08-19 | 3 | Dewey Christopher C | MYOS | Common Stock | D | 479,452 | ||||||||
2019-08-19 | 3 | Dewey Christopher C | MYOS | Common Stock | D | 479,452 | ||||||||
2019-03-27 | 2019-03-27 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.4600 | 171,233 | 250 | 689,210 | ||||
2019-03-27 | 2019-03-27 | 4 | PECHOCK CHRISTOPHER | MYOS | Common Stock | D | 1.4600 | 34,247 | 50 | 257,157 | ||||
2019-03-27 | 3 | MATLIN DAVID J | MYOS | Common Stock | D | 2,121,732 | ||||||||
2019-03-27 | 3 | MATLIN DAVID J | MYOS | Common Stock | D | 2,121,732 | ||||||||
2019-03-27 | 3 | MATLIN DAVID J | MYOS | Common Stock | D | 2,121,732 | ||||||||
2019-02-08 | 2019-02-06 | 4 | Aronne Louis J. | MYOS | Common Stock | D | 19,562 | 50,953 | ||||||
2019-02-08 | 2019-02-06 | 4 | MANDEL VICTOR E | MYOS | Common Stock | D | 29,930 | 79,055 | ||||||
2019-02-08 | 2019-02-06 | 4 | Mannello Joseph | MYOS | Common Stock | D | 14,085 | 517,977 | ||||||
2019-02-08 | 2019-02-06 | 4 | Nosta John | MYOS | Common Stock | D | 23,083 | 32,274 | ||||||
2019-02-08 | 2019-02-06 | 4 | PECHOCK CHRISTOPHER | MYOS | Common Stock | D | 29,930 | 222,910 | ||||||
2019-02-08 | 2019-02-06 | 4 | Hariri Robert J | MYOS | Common Stock | D | 10,955 | 116,058 | ||||||
2018-04-27 | 2018-04-25 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.2400 | 221,774 | 275 | 503,892 | ||||
2018-04-27 | 2018-04-25 | 4 | PECHOCK CHRISTOPHER | MYOS | Common Stock | D | 1.2400 | 80,645 | 100 | 192,980 | ||||
2018-01-05 | 2018-01-03 | 4 | PECHOCK CHRISTOPHER | MYOS | Common Stock | D | 11,949 | 112,335 | ||||||
2018-01-05 | 2018-01-03 | 4 | Hariri Robert J | MYOS | Common Stock | D | 7,353 | 105,103 | ||||||
2018-01-05 | 2018-01-03 | 4 | MANDEL VICTOR E | MYOS | Common Stock | D | 10,110 | 49,125 | ||||||
2018-01-05 | 2018-01-03 | 4 | Mannello Joseph | MYOS | Common Stock | D | 7,353 | 282,118 | ||||||
2018-01-05 | 2018-01-03 | 4 | Nosta John | MYOS | Common Stock | D | 9,191 | 9,191 | ||||||
2018-01-05 | 2018-01-03 | 4 | Aronne Louis J. | MYOS | Common Stock | D | 9,191 | 31,391 | ||||||
2017-12-26 | 2017-12-21 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.4600 | 20,336 | 30 | 274,765 | ||||
2017-12-08 | 2017-12-08 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.3500 | 5,500 | 7 | 254,429 | ||||
2017-12-08 | 2017-12-07 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.3600 | 15,800 | 21 | 249,429 | ||||
2017-12-08 | 2017-12-06 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.3500 | 16,819 | 23 | 233,629 | ||||
2017-11-16 | 2017-11-16 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.3500 | 12,150 | 16 | 216,810 | ||||
2017-11-16 | 2017-11-15 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.3100 | 1,100 | 1 | 204,660 | ||||
2017-11-16 | 2017-11-14 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.2700 | 11,750 | 15 | 203,560 | ||||
2017-08-28 | 2017-08-24 | 4 | Mannello Joseph | MYOS | Stock Option | D | 4.00 | 300,000 | 300,000 | |||||
2016-12-30 | 2016-12-28 | 4 | PECHOCK CHRISTOPHER | MYOS | Common Stock | D | 4,386 | 100,386 | ||||||
2016-12-30 | 2016-12-28 | 4 | Hariri Robert J | MYOS | Common Stock | D | 4,386 | 97,750 | ||||||
2016-12-30 | 2016-12-28 | 4 | MANDEL VICTOR E | MYOS | Common Stock | D | 1,755 | 39,015 | ||||||
2016-12-30 | 2016-12-28 | 4 | Mannello Joseph | MYOS | Common Stock | D | 2,631 | 191,810 | ||||||
2016-12-30 | 2016-11-15 | 4 | Mannello Joseph | MYOS | Common Stock | D | 10,000 | 189,179 | ||||||
2016-12-30 | 2016-12-28 | 4 | LYU ZHENGGUANG | MYOS | Common Stock | D | 4,386 | 122,228 | ||||||
2016-12-09 | 2016-12-02 | 4 | LYU ZHENGGUANG | MYOS | Common Stock | D | 1.5300 | 931 | 1 | 117,842 | ||||
2016-12-09 | 2016-12-01 | 4 | LYU ZHENGGUANG | MYOS | Common Stock | D | 1.5500 | 3,600 | 6 | 116,911 | ||||
2016-12-09 | 2016-12-01 | 4 | LYU ZHENGGUANG | MYOS | Common Stock | D | 1.4500 | 11,323 | 16 | 113,311 | ||||
2016-12-09 | 2016-11-30 | 4 | LYU ZHENGGUANG | MYOS | Common Stock | D | 1.4300 | 18,483 | 26 | 101,988 | ||||
2016-09-26 | 2016-09-23 | 4 | LYU ZHENGGUANG | MYOS | Common Stock | D | 1.6999 | 50,000 | 85 | 83,505 | ||||
2016-09-07 | 2016-09-06 | 4 | LYU ZHENGGUANG | MYOS | Common Stock | D | 1.5980 | 22,905 | 37 | 33,505 | ||||
2016-09-07 | 2016-09-01 | 4 | LYU ZHENGGUANG | MYOS | Common Stock | D | 1.6000 | 600 | 1 | 10,600 | ||||
2016-06-21 | 2016-06-17 | 4 | LYU ZHENGGUANG | MYOS | Common Stock | D | 1.6500 | 10,000 | 16 | 10,000 | ||||
2016-04-13 | 2016-04-11 | 4 | REN REN | MYOS | Common Stock | D | 18,182 | 18,182 | ||||||
2016-04-08 | 2016-04-08 | 4 | Mannello Joseph | MYOS | Common Stock | D | 2.0500 | 900 | 2 | 179,179 | ||||
2016-04-08 | 2016-04-07 | 4 | Mannello Joseph | MYOS | Common Stock | D | 2.0500 | 400 | 1 | 178,279 | ||||
2016-04-08 | 2016-04-06 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.9200 | 3,117 | 6 | 177,879 | ||||
2016-04-06 | 3 | Mannello Joseph | MYOS | Common Stock | D | 337,268 | ||||||||
2016-04-06 | 3 | Mannello Joseph | MYOS | Common Stock | D | 337,268 | ||||||||
2016-04-06 | 2016-04-05 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.7550 | 3,800 | 7 | 174,762 | ||||
2016-04-06 | 2016-04-04 | 4 | Mannello Joseph | MYOS | Common Stock | D | 1.7400 | 2,328 | 4 | 170,962 | ||||
2016-03-14 | 3 | RENS Agriculture Science & Technology Co, Ltd | MYOS | Common Stock | I | 3,000,000 | ||||||||
2016-03-14 | 3 | RENS Agriculture Science & Technology Co, Ltd | MYOS | Common Stock | I | 3,000,000 | ||||||||
2016-03-14 | 3 | RENS Agriculture Science & Technology Co, Ltd | MYOS | Common Stock | I | 3,000,000 | ||||||||
2016-03-14 | 3 | RENS Agriculture Science & Technology Co, Ltd | MYOS | Common Stock | I | 3,000,000 | ||||||||
2016-01-15 | 3 | LEVINE JACK | MYOS | Common Stock | D | 27,000 | ||||||||
2016-01-15 | 3 | LEVINE JACK | MYOS | Common Stock | D | 27,000 | ||||||||
2016-01-15 | 3 | MANDEL VICTOR E | MYOS | Common Stock | D | 74,520 | ||||||||
2016-01-15 | 3 | MANDEL VICTOR E | MYOS | Common Stock | D | 74,520 | ||||||||
2015-12-29 | 2015-12-24 | 4 | Toussaint Kenrick Bryce | MYOS | Common Stock | D | 10,000 | 10,000 | ||||||
2015-12-21 | 2015-12-17 | 4 | Hariri Robert J | MYOS | Common Stock | D | 2.7300 | 1,000 | 3 | 93,364 | ||||
2015-11-09 | 2015-11-06 | 4 | DosSantos Joseph | MYOS | Common Stock | D | 5,000 | 5,000 | ||||||
2015-09-30 | 2015-09-29 | 4 | Hariri Robert J | MYOS | Common Stock | D | 2.7000 | 1,500 | 4 | 92,364 | ||||
2015-09-30 | 2015-09-28 | 4 | Hariri Robert J | MYOS | Common Stock | D | 2.6500 | 800 | 2 | 90,864 | ||||
2015-09-25 | 2015-09-25 | 4 | Hariri Robert J | MYOS | Common Stock | D | 2.6900 | 1,400 | 4 | 90,064 | ||||
2015-09-25 | 2015-09-24 | 4 | Hariri Robert J | MYOS | Common Stock | D | 2.4800 | 4,500 | 11 | 88,664 | ||||
2015-09-25 | 2015-09-23 | 4 | Hariri Robert J | MYOS | Common Stock | D | 2.3600 | 6,250 | 15 | 84,164 | ||||
2015-09-11 | 2015-09-11 | 4 | Hariri Robert J | MYOS | Common Stock | D | 1.6500 | 1,000 | 2 | 77,914 | ||||
2015-09-11 | 2015-09-09 | 4 | Hariri Robert J | MYOS | Common Stock | D | 1.7500 | 3,000 | 5 | 76,914 | ||||
2015-09-08 | 2015-09-04 | 4 | Aronne Louis J. | MYOS | Common Stock | D | 1.7600 | 5,000 | 9 | 22,200 | ||||
2015-09-08 | 2015-09-08 | 4 | Hariri Robert J | MYOS | Common Stock | D | 1.7200 | 5,000 | 9 | 73,914 | ||||
2015-09-08 | 2015-09-04 | 4 | Hariri Robert J | MYOS | Common Stock | D | 1.7500 | 7,500 | 13 | 68,914 | ||||
2015-09-08 | 2015-09-03 | 4 | Hariri Robert J | MYOS | Common Stock | D | 1.7200 | 5,500 | 9 | 61,414 | ||||
2015-09-08 | 2015-09-01 | 4 | Hariri Robert J | MYOS | Common Stock | D | 1.7300 | 2,250 | 4 | 55,914 | ||||
2015-09-08 | 2015-08-31 | 4 | Hariri Robert J | MYOS | Common Stock | D | 1.6300 | 5,000 | 8 | 53,664 | ||||
2015-09-01 | 2015-08-28 | 4 | Hariri Robert J | MYOS | Common Stock | D | 1.7400 | 2,750 | 5 | 48,664 | ||||
2015-07-27 | 2015-07-23 | 4 | Hariri Robert J | MYOS | Common Stock | D | 3.2000 | 9,000 | 29 | 45,914 | ||||
2015-04-07 | 2015-03-30 | 4 | Hariri Robert J | MYOS | Common Stock | D | 4.7500 | 2,000 | 10 | 36,914 | ||||
2015-01-12 | 2015-01-12 | 4 | Aldrin Buzz | MYOS | Stock Option | D | 12.50 | 3,000 | 3,000 | |||||
2015-01-12 | 2015-01-12 | 4 | Venter John Craig | MYOS | Stock Option | D | 12.50 | 3,000 | 3,000 | |||||
2015-01-12 | 2015-01-12 | 4 | Srivastava Sapna | MYOS | Stock Option | D | 12.50 | 4,000 | 4,000 | |||||
2015-01-12 | 2015-01-12 | 4 | Levy Peter | MYOS | Stock Option | D | 12.50 | 10,000 | 10,000 | |||||
2015-01-12 | 2015-01-12 | 4 | Hariri Robert J | MYOS | Stock Option | D | 12.50 | 25,000 | 25,000 | |||||
2015-01-12 | 2015-01-12 | 4 | Hariri Robert J | MYOS | Stock Option | D | 12.50 | 3,000 | 3,000 | |||||
2015-01-12 | 2015-01-12 | 4 | PECHOCK CHRISTOPHER | MYOS | Stock Option | D | 12.50 | 6,000 | 6,000 | |||||
2015-01-12 | 2015-01-12 | 4 | Diamandis Peter | MYOS | Stock Option | D | 12.50 | 4,000 | 4,000 | |||||
2015-01-12 | 2015-01-12 | 4 | Aronne Louis J. | MYOS | Stock Option | D | 12.50 | 6,000 | 6,000 | |||||
2015-01-12 | 2015-01-12 | 4 | DosSantos Joseph | MYOS | Stock Option | D | 12.50 | 10,000 | 10,000 | |||||
2015-01-12 | 2015-01-12 | 4 | Ashton Robert C. Jr. | MYOS | Stock Option | D | 12.50 | 10,000 | 10,000 | |||||
2014-12-29 | 2014-12-12 | 4 | Hariri Robert J | MYOS | Common Stock | D | 7.8400 | 1,000 | 8 | 34,914 | ||||
2014-12-04 | 2014-12-04 | 4 | Hariri Robert J | MYOS | Common Stock | D | 7.9200 | 200 | 2 | 33,914 | ||||
2014-12-04 | 2014-12-02 | 4 | Hariri Robert J | MYOS | Common Stock | D | 8.1880 | 2,000 | 16 | 33,714 | ||||
2014-08-18 | 2014-08-18 | 4 | Diamandis Peter | MYOS | Common Stock | D | 14.5100 | 3,444 | 50 | 5,444 | ||||
2014-07-14 | 2014-07-09 | 4 | Venter John Craig | MYOS | Stock Option | D | 13.00 | 14,600 | 14,600 | |||||
2014-05-20 | 2014-05-19 | 4 | DosSantos Joseph | MYOS | Stock Option | D | 12.55 | 20,000 | 20,000 | |||||
2014-05-09 | 2014-05-07 | 4 | Hariri Robert J | MYOS | Stock Option | D | 12.10 | 30,000 | 30,000 | |||||
2014-03-12 | 2014-03-10 | 4 | Hariri Robert J | MYOS | Stock Option | D | 8.60 | 2,500 | 2,500 | |||||
2014-03-12 | 2014-03-10 | 4 | Aronne Louis J. | MYOS | Stock Option | D | 8.60 | 7,500 | 7,500 | |||||
2014-03-12 | 2014-03-10 | 4 | Diamandis Peter | MYOS | Stock Option | D | 8.60 | 2,500 | 2,500 | |||||
2014-03-12 | 2014-03-10 | 4 | Levy Peter | MYOS | Stock Option | D | 8.60 | 4,000 | 4,000 | |||||
2014-03-12 | 2014-03-10 | 4 | Aldrin Buzz | MYOS | Stock Option | D | 8.60 | 2,500 | 2,500 | |||||
2014-03-12 | 2014-03-10 | 4 | Srivastava Sapna | MYOS | Stock Option | D | 8.60 | 2,500 | 2,500 | |||||
2014-03-05 | 2014-03-03 | 4 | Aronne Louis J. | MYOS | Common Stock | D | 2,000 | 17,200 | ||||||
2014-02-24 | 3 | PECHOCK CHRISTOPHER | MYOS | Common Stock | D | 196,000 | ||||||||
2014-02-24 | 3 | PECHOCK CHRISTOPHER | MYOS | Common Stock | D | 196,000 | ||||||||
2014-02-24 | 3 | PECHOCK CHRISTOPHER | MYOS | Common Stock | I | 104,000 | ||||||||
2014-02-24 | 3 | PECHOCK CHRISTOPHER | MYOS | Common Stock | I | 104,000 | ||||||||
2014-02-19 | 2014-02-18 | 4 | DeFreitas Carl | MYOS | Stock Option | D | 12.50 | 8,000 | 8,000 | |||||
2014-02-04 | 2014-02-03 | 4 | Srivastava Sapna | MYOS | Stock Option | D | 0.15 | 150,000 | 150,000 | |||||
2013-12-02 | 2013-11-27 | 4 | DeFreitas Carl | MYOS | Stock Option | D | 0.25 | 100,000 | 100,000 | |||||
2013-12-02 | 2013-08-21 | 4 | DeFreitas Carl | MYOS | Stock Option | D | 0.25 | 50,000 | 50,000 | |||||
2013-10-10 | 2013-10-08 | 4 | Srivastava Sapna | MYOS | Stock Option | D | 0.12 | 150,000 | 150,000 | |||||
2013-07-24 | 2013-07-01 | 4 | Srivastava Sapna | MYOS | Stock Option | D | 0.19 | 150,000 | 150,000 | |||||
2013-07-24 | 2013-04-01 | 4 | Srivastava Sapna | MYOS | Stock Option | D | 0.14 | 150,000 | 150,000 | |||||
2013-05-17 | 2013-04-25 | 4 | Fleischer Glen R. | MYOS | Common Stock | D | -5,000,000 | 0 | ||||||
2013-03-04 | 2013-02-28 | 4 | DeFreitas Carl | MYOS | Stock Option | D | 0.25 | 100,000 | 100,000 | |||||
2013-02-19 | 3 | DeFreitas Carl | MYOS | Common Stock | D | 1,000 | ||||||||
2013-02-15 | 2013-02-07 | 4 | Hariri Robert J | MYOS | Stock Option | D | 0.35 | 5,000,000 | 5,000,000 | |||||
2013-02-15 | 3 | Srivastava Sapna | MYOS | Common Stock | D | 100,000 | ||||||||
2013-02-15 | 2013-02-08 | 4 | Srivastava Sapna | MYOS | Stock Option | D | 0.20 | 250,000 | 250,000 | |||||
2013-02-15 | 2013-02-08 | 4 | Srivastava Sapna | MYOS | Common Stock | D | 100,000 | 200,000 | ||||||
2013-01-09 | 2013-01-07 | 4 | Hariri Robert J | MYOS | Stock Option | D | 0.25 | 250,000 | 250,000 | |||||
2013-01-09 | 2013-01-07 | 4 | Aronne Louis J. | MYOS | Stock Option | D | 0.25 | 250,000 | 250,000 | |||||
2013-01-09 | 2013-01-07 | 4 | Diamandis Peter | MYOS | Stock Option | D | 0.25 | 250,000 | 250,000 | |||||
2013-01-09 | 2013-01-07 | 4 | Levy Peter | MYOS | Stock Option | D | 0.25 | 1,000,000 | 1,000,000 | |||||
2013-01-09 | 2012-11-20 | 4 | Levy Peter | MYOS | Stock Option | D | 0.20 | 2,000 | 2,000 | |||||
2013-01-09 | 2013-01-07 | 4 | Aldrin Buzz | MYOS | Stock Option | D | 0.25 | 250,000 | 250,000 | |||||
2013-01-08 | 2013-01-02 | 4 | Fleischer Glen R. | MYOS | Common Stock | D | 5,000,000 | 5,000,000 | ||||||
2012-12-03 | 2012-07-06 | 4 | Aronne Louis J. | MYOS | Common Stock | D | 0.2500 | 160,000 | 40 | 760,000 | ||||
2012-07-02 | 2012-06-29 | 4 | Hariri Robert J | MYOS | 18% Convertible Promissory Note | D | 0.20 | 0 | ||||||
2012-07-02 | 2012-06-29 | 4 | Hariri Robert J | MYOS | Common Stock | D | 0.2000 | 507,306 | 101 | 9,885,681 | ||||
2012-07-02 | 2012-06-29 | 4 | Hariri Robert J | MYOS | Common Stock | D | 0.2000 | 828,375 | 166 | 9,378,375 | ||||
2012-05-31 | 2012-05-24 | 4 | Aldrin Buzz | MYOS | Stock Option | D | 0.14 | 250,000 | 250,000 | |||||
2012-05-31 | 2012-05-24 | 4 | Aldrin Buzz | MYOS | Common Stock | D | 100,000 | 100,000 | ||||||
2012-05-08 | 2012-05-07 | 4 | Levy Peter | ATTH | Common Stock | D | 250,000 | 750,000 | ||||||
2012-02-14 | 2012-02-10 | 4 | Levy Peter | ATTH | Common Stock | D | 500,000 | 500,000 | ||||||
2012-02-09 | 2011-10-14 | 5 | DiVenuto Janine | ATTH | Common Stock | D | 0.2400 | 1,000 | 0 | 7,757,000 | ||||
2012-02-09 | 2011-10-11 | 5 | DiVenuto Janine | ATTH | Common Stock | D | 0.2000 | 1,000 | 0 | 7,756,000 |